11 Cheap Pharmaceutical Stocks to Buy Now
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the steps they should take to decrease the prices of US prescription drugs to “most...
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Polaris Capital Management Bernard Horn | 324,900 | $36,021,663 | -10% | 2.4% |
| 2. | Motley Fool Asset Management Bryan Hinmon | 81,254 | $9,008,631 | +15% | 0.42% |
| 3. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 73,165 | $8,111,804 | -5% | 3.47% |
| 4. | Lee Munder Capital Group Lee Munder | 17,797 | $1,973,153 | -43% | 0.12% |
| 5. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 11,033 | $1,223,229 | -23% | 0.55% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | $999,150.00 | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | $430,493.00 | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | $439,955.00 | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | $335,974.40 | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | $158,064.64 | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $114.09 | 8,345 | $952,076.88 | 605,725 | 2025-07-28 | Filing | |
| $113.17 | 1,655 | $187,292.71 | 614,070 | 2025-07-28 | Filing | |
| $111.03 | 3,000 | $333,090.00 | 117,168 | 2025-07-15 | Filing | |
| $111.03 | 2,500 | $277,575.00 | 162,610 | 2025-07-15 | Filing | |
| $109.74 | 5,000 | $548,700.00 | 8,920 | 2025-07-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,224,117 | $690,067,852 | 0.83% | |
| 2. | 3,956,933 | $436,647,557 | 0.41% | |
| 3. | 3,742,656 | $414,948,273 | 0.67% | |
| 4. | 3,420,676 | $379,250,348 | 0.32% | |
| 5. | 3,378,055 | $374,524,958 | 1.9% |
News See All
Citi Maintains a Buy Rating on Gilead Sciences (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the top low volatility healthcare stocks to buy now.
TD Cowen Remains Bullish on Gilead Sciences (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most profitable biotech stocks to invest in now. TD Cowen analyst Tyler Van Buren maintained a Buy rating on Gilead Sciences, Inc.
10 Most Profitable Biotech Stocks to Invest in Now
Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s 'Power Lunch' on March 5 to talk about investing in biotech and the oversaturation in the sector.
Top 15 Low Volatility Healthcare Stocks to Buy Now
A majority of Americans have experienced the frustration of getting a healthcare insurance denial, often times finding no solution despite emails with service providers and phone calls with carriers.
Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector
The company rose to prominence during the COVID-19 pandemic thanks to its antiviral drug remdesivir, one of the earliest approved treatments for the virus.
14 Best Pharma Dividend Stocks to Buy in 2025
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 pandemic, expanded collaborations across the value chain, and ongoing changes in...
Bernstein Maintains Buy Rating on Gilead Sciences (GILD) Stock
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the Best Large Cap Value Stocks to Invest In.
Gilead Sciences (GILD) Reaches Deal to Offer HIV Vaccine to Low and Middle-Income Nations
Gilead Sciences, Inc. (NASDAQ:GILD) is one of Goldman Sachs’ top healthcare stock picks.
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector has been under pressure, underperforming the S&P 500 over the past several years.
Billionaire Hedge Funds
